Back to results
US 2026/0007664 A1Published application
Methods of improving lung function
AssigneeEndeavor BioMedicines, Inc.
InventorsMiguel de los Rios, John Hood, Anita J. DiFrancesco, Luis A. Dellamary, Paul A. Frohna
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of treating pulmonary fibrosis, the methods comprising administering taladegib to a subject in need thereof.
Claims30
1-30. (canceled)
A method of slowing progression of pulmonary fibrosis, the method comprising administering taladegib, or a pharmaceutically acceptable salt thereof, to a subject suffering from or diagnosed with pulmonary fibrosis according to a treatment regimen that improves lung function in the subject, wherein the improvement in lung function comprises one or more of the following:
- an increase in total lung capacity (TLC) as compared to baseline TLC;
- a reduction in one or more measures of lung fibrosis;
- an increase in lung volume;
- or
- reducing pulmonary vascular volume.
2 more elements
Dependencies are inferred from the claim text.